p53 Abnormal Oral Epithelial Dysplasias are Associated With High Risks of Progression and Local RecurrencedA Retrospective Study in a Longitudinal Cohort

被引:1
|
作者
Ko, Yen Chen Kevin [1 ,2 ,3 ]
Liu, Kelly Yi Ping [3 ,4 ,5 ]
Chen, Esther [3 ]
Zhu, Sarah Yuqi [3 ,4 ]
Poh, Catherine F. [3 ,4 ]
机构
[1] BC Canc, Dept Pathol, Vancouver, BC, Canada
[2] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada
[3] Univ British Columbia, Fac Dent, Dept Oral Med Biol Sci, Vancouver, BC, Canada
[4] BC Canc, Dept Integrat Oncol, Vancouver, BC, Canada
[5] Univ British Columbia, Fac Appl Sci, Fac Med, Sch Biomed Engn, Vancouver, BC, Canada
关键词
TP53; p53; oral dysplasia; human papillomavirus; oral epithelial dysplasia;
D O I
10.1016/j.modpat.2024.100613
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Grading of oral epithelial dysplasia (OED) can be challenging with considerable intraobserver and interobserver variability. Abnormal immunohistochemical staining patterns of the tumor suppressor protein, p53, have been recently shown to be potentially associated with progression in OED. We retrospectively identified 214 oral biopsies from 203 patients recruited in a longitudinal study between 2001 and 2008 with a diagnosis of reactive, nondysplastic lesions, low-grade lesions (mild OED and moderate OED) and high-grade lesions (HGLs; severe OED/carcinoma in situ). Tissue microarrays were constructed from the most representative area of the pathology. Three consecutive sections were sectioned and stained for hematoxylin and eosin, p53 immunohistochemistry, and p16 immunohistochemistry. The staining results were reviewed by 2 pathologists (Y.C.K.K., C.F.P.) blinded to clinical outcome. Samples were categorized into p53 abnormal OED (n = 46), p53 conventional OED (n = 118), and p53 human papillomavirus (HPV) OED (HPV associated) (n = 12) using a previously published pattern-based approach. All cases of p53 HPV OED (HPV associated) were identified in HGLs. In contrast, cases of p53 abnormal OED were observed in mild OED (9.5%), moderate OED (23%), and severe OED/carcinoma in situ (51%). None of the 27 reactive or nondysplastic lesions showed abnormal p53 staining patterns. Among the 135 low-grade lesions, 23 cases (17.0%; 2 mild OEDs and 21 moderate OEDs) progressed to HGL or squamous cell carcinoma, with 11 cases showing progression within the first 3 years. Remarkably, 82% (9/11) of these faster progressors showed abnormal p53 patterns. Survival analysis revealed that p53 abnormal OED had significantly poorer progression-free probability (P < .0001) with hazard ratio of 11.24 (95% CI, 4.26-29.66) compared with p53 conventional OED. Furthermore, p53 abnormal OED had poorer local recurrenceefree survival compared with p53 wildtype OED (P = .03). The study supports that OED with p53 abnormal pattern is at high risk for progression and recurrence independent of the dysplasia grade. (c) 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Indefinite for Dysplasia Diagnosed in Barrett's Esophagus by Expert Pathologists is Associated with a High Risk for Progression to Neoplasia: A Retrospective Cohort Study
    Frei, Nicola F.
    Marciello, Giuliana
    Jochum, Wolfram
    Brand, Stephan
    Borovicka, Jan
    SWISS MEDICAL WEEKLY, 2022, 152 : 5S - 5S
  • [42] Impact of Early Relapse (Pod 24) & p53 Alterations on Treatment Outcomes in Patients With Mantle Cell Lymphoma: Multicentre, Retrospective Cohort Study in Ireland
    Elhassadi, Ezzat
    Hennessy, Brian
    Kumar, Senthil
    Sutton, Louise
    Mutaz, Nur
    Shatwan, Ramadan
    Quinn, Anne
    Catherwood, Mark
    Hayat, Amjad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S513 - S514
  • [43] Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study
    Drysdale, Myriam
    Tibble, Holly
    Patel, Vishal
    Gibbons, Daniel C.
    Lloyd, Emily J.
    Kerr, William
    Macdonald, Calum
    Birch, Helen J.
    Sheikh, Aziz
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [44] Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland
    Cruz, I
    Napier, SS
    van der Waal, I
    Snijders, PJF
    Walboomers, JMM
    Lamey, PJ
    Cowan, CG
    Gregg, TA
    Maxwell, P
    Meijer, CJLM
    JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (02) : 98 - 104
  • [45] Clinical and Molecular Variables Associated With Early Progression to Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer: A Retrospective Cohort Study
    Hulst, L.
    Cappuyns, S.
    Peeters, F.
    Vulsteke, F.
    Van Herpe, F.
    Van Cutsem, E.
    Dekervel, J.
    CLINICAL COLORECTAL CANCER, 2024, 23 (03)
  • [46] Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients-A retrospective cohort study on 5392 patients from a tertiary centre
    Bistrovic, Petra
    Sabljic, Anica
    Kovacevic, Ivona
    Cikara, Tomislav
    Keres, Tatjana
    Lucijanic, Tomo
    Mitrovic, Josko
    Delic-Brkljacic, Diana
    Manola, Sime
    Lucijanic, Marko
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 372 : 144 - 149
  • [47] Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia
    Kurokawa, H
    Matsumoto, S
    Murata, T
    Yamashita, Y
    Tomoyose, T
    Zhang, M
    Fukuyama, H
    Takahashi, T
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2003, 32 (09) : 513 - 521
  • [48] Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study
    Patel, Vishal
    Yarwood, Marcus J.
    Levick, Bethany
    Gibbons, Daniel C.
    Drysdale, Myriam
    Kerr, William
    Watkins, Jonathan D.
    Young, Sophie
    Pierce, Benjamin F.
    Lloyd, Emily J.
    Birch, Helen J.
    Kamalati, Tahereh
    Brett, Stephen J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (08) : 1323 - 1334
  • [49] Features of Extramedullary Disease of Multiple Myeloma: High Frequency of P53 Deletion and Poor Survival: A Retrospective Single-Center Study of 834 Cases
    Deng, Shuhui
    Xu, Yan
    An, Gang
    Sui, Weiwei
    Zou, Dehui
    Zhao, Yaozhong
    Qi, Junyuan
    Li, Fei
    Hao, Mu
    Qiu, Lugui
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (05): : 286 - 291
  • [50] CELLULAR IMMORTALITY - A LATE EVENT IN THE PROGRESSION OF HUMAN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK ASSOCIATED WITH P53 ALTERATION AND A HIGH-FREQUENCY OF ALLELE LOSS
    EDINGTON, KG
    LOUGHRAN, OP
    BERRY, IJ
    PARKINSON, EK
    MOLECULAR CARCINOGENESIS, 1995, 13 (04) : 254 - 265